Search results
Results from the WOW.Com Content Network
Menopause is usually diagnosed through symptoms of vaginal atrophy, pelvic exams, and taking a comprehensive medical history consisting of last menstruation cycle. There is no definitive testing available for determining menopause as the symptom complex is the primary indicator [ 5 ] and because the lower levels of estradiol are harder to ...
On 28 June 2013 FDA approved Brisdelle (low-dose paroxetine mesylate) for the treatment of moderate-to-severe vasomotor symptoms (e.g. hot flashes and night sweats) associated with menopause. Paroxetine became the first and only non-hormonal therapy for menopausal hot flashes approved by FDA. [29]
If you’re healthy, under age 60, and it’s been ten years or less since the onset of menopause, systemic therapy with estrogen is the most effective treatment for vasomotor symptoms, according ...
Menopause is a natural biological process. For some, it happens in their 40s while others start later in life in their 50s (the average age is 51 in the United States, according to Mayo Clinic).
However, there is insufficient evidence to suggest that exercise helps with the symptoms of menopause. [21] Similarly, yoga has not been shown to be useful as a treatment for vasomotor symptoms. [21] However a high BMI is a risk factor for vasomotor symptoms in particular. Weight loss may help with symptom management.
Together with data from two earlier studies, Bayer would file requests for approval for the treatment of moderate to severe vasomotor symptoms, also known as hot flashes, associated with menopause.
Hormone replacement therapy (HRT), also known as menopausal hormone therapy or postmenopausal hormone therapy, is a form of hormone therapy used to treat symptoms associated with female menopause. [ 1 ] [ 2 ] Effects of menopause can include symptoms such as hot flashes , accelerated skin aging, vaginal dryness , decreased muscle mass , and ...
The study, which involved 106 peri- and postmenopausal women and was presented at the Endocrine Society’s annual meeting in May, indicates women should self-monitor their vasomotor symptoms and ...